{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:42:04Z","timestamp":1795027324827,"version":"4.10.2"},"reference-count":37,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objective: Long COVID is an important cause of disability following SARS-CoV-2 infection; yet, its underlying mechanisms are not completely understood. One proposed mechanism is the long-lasting dysregulation of the immune complement system. This systematic review is the first to summarize the current evidence and evaluate the potential role of long-lasting complement activation in people with long COVID. Methods: A systematic electronic search on PubMed, MEDLINE, CINAHL, and Embase was conducted up to 15 October 2025, to identify studies investigating complement activation in people with the post-COVID-19 condition. The Newcastle\u2013Ottawa Scale was used to evaluate the risk of bias and methodological quality. Results: Among the 247 studies initially identified, eleven met the inclusion criteria, comprising 1435 individuals (age: 48.5 years, 70% females) with long COVID and 1124 controls (age: 43.6 years, 60% females). All studies were of a high quality, with scores ranging from 7 to 8 stars (mean: 7.6 \u00b1 0.5). The activation of the classical complement pathway was investigated in nine studies, whereas the lectin, alternative, and terminal complement pathways were each assessed in three studies. Multiple studies investigated several complement pathways. The results were heterogeneous since several markers of complement activation spanning the classical (C2, C4a, C4b, and C1s-C1INH), alternative (Ba, iC3b, and Factor D), and terminal (C5bC6, C5a, C9, and TCC) pathways were elevated, whereas other markers were not significantly different (C3, C4, and C4d) between patients with\/without long COVID. In addition, markers spanning the lectin complement pathway (MBL, and MASP1-C1INH) were not significantly different between individuals with and without long COVID. Conclusions: The current evidence suggests potential long-lasting complement system dysregulation in individuals with long COVID, although the clinical significance remains controversial, due to heterogenous findings. Specific post-COVID symptom clusters, such as fatigue, dyspnea, or brain fog, have been linked to a distinct pattern of complement dysregulation. Substantial methodological heterogeneity, including differences in follow-up periods, complement markers, assessment methods, and control groups, along with the small number of available studies, underscores the need for further research to clarify the mechanisms linking complement dysregulation to long COVID.<\/jats:p>","DOI":"10.3390\/biomedicines14020439","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:37:28Z","timestamp":1771245448000},"page":"439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complement System Dysregulation in the Immunopathogenesis of Long COVID: Systematic Evidence Synthesis"],"prefix":"10.3390","volume":"14","author":[{"given":"Kin Israel","family":"Notarte","sequence":"first","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1845-759X","authenticated-orcid":false,"given":"Jesus Alfonso","family":"Catahay","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Veronica","family":"Velasco","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardinal Santos Medical Center, San Juan City, Metro Manila 1502, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbygail Therese","family":"Ver","sequence":"additional","affiliation":[{"name":"Alliance for Improving Health Outcomes, Quezon City, Metro Manila 1104, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungwook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biology, Johns Hopkins University, Baltimore, MD 21218, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-8695","authenticated-orcid":false,"given":"John G.","family":"Rizk","sequence":"additional","affiliation":[{"name":"Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9523-9054","authenticated-orcid":false,"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[{"name":"Section of Clinical Biochemistry, University of Verona, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3772-9690","authenticated-orcid":false,"given":"C\u00e9sar","family":"Fern\u00e1ndez-de-las-Pe\u00f1as","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, 28922 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"ofae462","DOI":"10.1093\/ofid\/ofae462","article-title":"Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach","volume":"11","author":"Griffin","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13643-023-02250-0","article-title":"systematic review and meta-analysis of long COVID symptoms","volume":"12","author":"Natarajan","year":"2023","journal-title":"Syst. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinf.2023.12.004","article-title":"Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis","volume":"88","author":"Notarte","year":"2024","journal-title":"J. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","article-title":"SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)","volume":"24","author":"Proal","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41401-022-00998-0","article-title":"Endothelial dysfunction in COVID-19: An overview of evidence, biomarkers, mechanisms and potential therapies","volume":"44","author":"Xu","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Notarte, K.I., Carandang, T.H.D.C., Velasco, J.V., Pastrana, A., Ver, A.T., Manalo, G.N., Ng, J.A., Grecia, S., Lippi, G., and Henry, B.M. (2024). Autoantibodies in COVID-19 survivors with post-COVID symptoms: A systematic review. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1428645"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e86015","DOI":"10.7554\/eLife.86015","article-title":"RECOVER Mechanistic Pathways Task Force. Viral persistence, reactivation, and mechanisms of long COVID","volume":"12","author":"Chen","year":"2023","journal-title":"eLife"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: Approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ajpath.2020.02.006","article-title":"Complement Membrane Attack Complex","volume":"190","author":"Xie","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1002\/mco2.785","article-title":"The dysfunction of complement and coagulation in diseases: The implications for the therapeutic interventions","volume":"5","author":"Jiang","year":"2024","journal-title":"MedComm"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"152393","DOI":"10.1016\/j.imbio.2023.152393","article-title":"Complement and COVID-19: Three years on, what we know, what we don\u2019t know, and what we ought to know","volume":"228","author":"Zelek","year":"2023","journal-title":"Immunobiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"eadg7942","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active Long Covid","volume":"383","author":"Hoch","year":"2024","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"ref_15","unstructured":"Wells, G., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M., and Tugwell, P. (2025, November 01). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. The Ottawa Hospital. Available online: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jiac.2023.10.016","article-title":"Relevance of complement immunity with brain fog in patients with long COVID","volume":"30","author":"Hagiya","year":"2024","journal-title":"J. Infect. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s40478-023-01662-2","article-title":"Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles","volume":"11","author":"Aschman","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.medj.2024.01.011","article-title":"Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID","volume":"5","author":"Baillie","year":"2024","journal-title":"Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41590-024-01778-0","article-title":"Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease","volume":"25","author":"Liew","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"110162","DOI":"10.1016\/j.isci.2024.110162","article-title":"sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID","volume":"27","author":"Hurler","year":"2024","journal-title":"iScience"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"108032","DOI":"10.1016\/j.ijid.2025.108032","article-title":"Classic pathway persistent complement activation is associated with specific symptoms in individuals with post\u2013COVID-19 condition: A case-control study","volume":"159","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bulla, R., Rossi, L., Furlanis, G., Agostinis, C., Toffoli, M., Balduit, A., Mangogna, A., Liccari, M., Morosini, G., and Kishore, U. (2023). A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1191083"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00216-024-05684-0","article-title":"Long-term dysregulation of plasma peptidome in mild and multiple COVID-19 recovered patients revealed by a novel efficient peptidomics workflow","volume":"417","author":"Song","year":"2025","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wei, Y., Gu, H., Ma, J., Mao, X., Wang, B., Wu, W., Yu, S., Wang, J., Zhao, H., and He, Y. (2024). Proteomic and metabolomic profiling of plasma uncovers immune responses in patients with Long COVID-19. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1470193"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Biondi, M.J., Addo, M., Zahoor, M.A., Salvant, E., Yip, P., Barber, B., Smookler, D., Wasif, S., Gaete, K., and Kandel, C. (2024). Differential gene expression in the upper respiratory tract following acute COVID-19 infection in ambulatory patients that develop long COVID. Pathogens, 13.","DOI":"10.3390\/pathogens13060510"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1515\/cclm-2024-0036","article-title":"Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms: A systematic review of the literature","volume":"62","author":"Macasaet","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e29676","DOI":"10.1002\/jmv.29676","article-title":"Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms 2 years after hospitalization: The VIPER study","volume":"96","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41590-025-02353-x","article-title":"Long COVID involves activation of proinflammatory and immune exhaustion pathways","volume":"27","author":"Aid","year":"2026","journal-title":"Nat. Immunol."},{"key":"ref_30","first-page":"e52991","article-title":"Complements and their role in systemic disorders","volume":"16","author":"Wang","year":"2024","journal-title":"Cureus"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e1279","DOI":"10.1002\/cti2.1279","article-title":"Autoantibodies against complement component C1q in systemic lupus erythematosus","volume":"10","author":"Trendelenburg","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12016-025-09110-w","article-title":"COVID-19-associated autoimmune and inflammatory diseases: Molecular mechanisms and the role of IVIG therapy","volume":"68","author":"Bordoloi","year":"2025","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2023.05.003","article-title":"Characterization of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis","volume":"134","author":"Kuodi","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gaya da Costa, M., Poppelaars, F., van Kooten, C., Mollnes, T.E., Tedesco, F., W\u00fcrzner, R., Trouw, L.A., Truedsson, L., Daha, M.R., and Roos, A. (2018). Age and sex-associated changes of complement activity and complement levels in a healthy Caucasian population. Front Immunol., 9.","DOI":"10.3389\/fimmu.2018.02664"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zheng, R., Zhang, Y., Zhang, K., Yuan, Y., Jia, S., and Liu, J. (2022). The complement system, aging, and aging-related diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158689"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E1433","DOI":"10.1152\/ajpendo.00664.2006","article-title":"Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance","volume":"292","author":"Zhang","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/2\/439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:04:36Z","timestamp":1771247076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/2\/439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["biomedicines14020439"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14020439","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]}}}